Abstract:Summary Streptozotocin (STZ), a glucosamine-nitrosourea compound, has potent genotoxic effects on pancreatic β-cells and is frequently used to induce diabetes in experimental animals. Glucagon-like peptide-1 (GLP-1) has β-cell protective effects and is known to preserve β-cells from STZ treatment. In this study, we analyzed the mechanisms of STZ-induced diabetes and GLP-1-mediated β-cell protection in STZ-treated mice. At 1 week after multiple low-dose STZ administrations, pancreatic β-cells showed impaired insulin expression, while maintaining expression of nuclear Nkx6.1. This was accompanied by significant upregulation of p53-responsive genes in islets, including a mediator of cell cycle arrest, p21 (also known as Waf1 and Cip1). STZ treatment also suppressed expression of a wide range of genes linked with key β-cell functions or diabetes development, such as G6pc2, Slc2a2 (Glut2), Slc30a8, Neurod1, Ucn3, Gad1, Isl1, Foxa2, Vdr, Pdx1, Fkbp1b and Abcc8, suggesting global β-cell defects in STZ-treated islets. The Tmem229B, Prss53 and Ttc28 genes were highly expressed in untreated islets and strongly suppressed by STZ, suggesting their potential roles in β-cell function. When a pancreas-targeted adeno-associated virus (AAV) vector was employed for long-term Glp-1 gene delivery, pancreatic GLP-1 expression protected mice from STZ-induced diabetes through preservation of the β-cell mass. Despite its potent β-cell protective effects, however, pancreatic GLP-1 overexpression showed limited effects on the global gene expression profiles in the islets. Network analysis identified the programmed-cell-death-associated pathways as the most relevant network in Glp-1 gene therapy. Upon pancreatic GLP-1 expression, upregulation of Cxcl13 and Nptx2 was observed in STZ-damaged islets, but not in untreated normal islets. Given the pro-β-cell-survival effects of Cxcl12 (Sdf-1) in inducing GLP-1 production in α-cells, pancreatic GLP-1-mediated Cxcl13 induction might also play a crucial role in maintaining the integrity of β-cells in damaged islets.

Selective Deletion of Pten in Pancreatic Β Cells Leads to Increased Islet Mass and Resistance to STZ-Induced Diabetes

Pancreas-specific Pten deficiency causes partial resistance to diabetes and elevated hepatic AKT signaling

Insulin Hypersensitivity and Resistance to Streptozotocin-Induced Diabetes in Mice Lacking Pten in Adipose Tissue

Reversal of Streptozotocin-Induced Diabetes in Rats by Gene Therapy with Betacellulin and Pancreatic Duodenal Homeobox-1

Pancreatic-specific Inactivation of IGF-I Gene Causes Enlarged Pancreatic Islets and Significant Resistance to Diabetes.

Human Expandable Pancreatic Progenitor–derived Β Cells Ameliorate Diabetes

In Vivo Targeted Delivery of ANGPTL8 Gene for Beta Cell Regeneration in Rats

Disruption of Growth Factor Receptor–Binding Protein 10 in the Pancreas Enhances Β-Cell Proliferation and Protects Mice from Streptozotocin-Induced Β-Cell Apoptosis

Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy

PTENless means more.

Inhibition of TBK1/IKKε Promotes Regeneration of Pancreatic β-cells

Constitutive Pleiotrophin Deletion Results in a Phenotype with an Altered Pancreatic Morphology and Function in Old Mice

Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes

Deletion of the RabGAP TBC1D1 Leads to Enhanced Insulin Secretion and Fatty Acid Oxidation in Islets From Male Mice

Restoration of PITPNA in Type 2 diabetic human islets reverses pancreatic beta-cell dysfunction

P21cip-overexpression in the Mouse Beta Cells Leads to the Improved Recovery from Streptozotocin-Induced Diabetes.

Effect of Phosphatase and Tensin Homologue Deleted on Chromosome Ten on the Cell Cycle and Proliferation of Pancreatic Cancer Cell Line

Relationship between PTEN and insulin resistance, type 2 diabetes mellitus

Expansion and Maintenance of CD133-Expressing Pancreatic Ductal Epithelial Cells by Inhibition of TGF-β Signaling.

Tectorigenin Enhances PDX1 Expression and Protects Pancreatic Β-Cells by Activating ERK and Reducing ER Stress

The role of PTEN in pancreatic ductal adenocarcinoma